We are live on ! Find out more
CS

Credit Suisse Portfolio holdings

AUM $104B
1-Year Est. Return 34.76%
This Fund
S&P 500
This Quarter Est. Return
+26.38%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+398.7%
AUM
$140B
AUM Growth
+$23.9B
Cap. Flow
-$1.4B
Cap. Flow %
-1%
Top 10 Hldgs %
16.71%
Holding
4,310
New
356
Increased
1,988
Reduced
1,282
Closed
383

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$1.02B
2
AMZN icon
Amazon
AMZN
+$922M
3
AAPL icon
Apple
AAPL
+$920M
4
OTIS icon
Otis Worldwide
OTIS
+$525M
5
TCOM icon
Trip.com Group
TCOM
+$523M

Sector Composition

Rank Sector Weight
1 Technology 17.27%
2 Healthcare 11.06%
3 Consumer Discretionary 9.06%
4 Financials 8.78%
5 Communication Services 7.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CCL icon
2626
PUT
Carnival Corporation Ltd
CCL
$39.4B
$1.34M ﹤0.01%
+81,800
New +$1.23M
EPAC icon
2627
Enerpac Tool Group
EPAC
$1.92B
$1.34M ﹤0.01%
76,142
+24,585
+48% +$415K
FBP icon
2628
First Bancorp
FBP
$4.44B
$1.33M ﹤0.01%
238,143
+84,301
+55% +$457K
MEOH icon
2629
Methanex
MEOH
$4.21B
$1.33M ﹤0.01%
73,576
-34,313
-32% -$570K
MTOR
2630
DELISTED
MERITOR, Inc.
MTOR
$1.33M ﹤0.01%
66,980
+1,849
+3% +$34.2K
LKFN icon
2631
Lakeland Financial Corp
LKFN
$1.55B
$1.33M ﹤0.01%
28,467
+7,235
+34% +$296K
NVRI icon
2632
Enviri
NVRI
$630M
$1.32M ﹤0.01%
98,126
+35,233
+56% +$354K
VNDA icon
2633
Vanda Pharmaceuticals
VNDA
$308M
$1.32M ﹤0.01%
115,780
+77,822
+205% +$881K
SEM
2634
DELISTED
Select Medical
SEM
$1.32M ﹤0.01%
166,624
-2,803
-2% -$23.2K
EFSC icon
2635
Enterprise Financial Services Corp
EFSC
$2.4B
$1.32M ﹤0.01%
42,434
+17,137
+68% +$498K
AVNS
2636
DELISTED
Avanos Medical
AVNS
$1.32M ﹤0.01%
44,874
+10,198
+29% +$295K
JELD icon
2637
JELD-WEN Holding
JELD
$154M
$1.32M ﹤0.01%
81,792
+44,275
+118% +$584K
NWN icon
2638
Northwest Natural Holdings
NWN
$2.14B
$1.31M ﹤0.01%
23,572
+725
+3% +$44.3K
TENB icon
2639
Tenable Holdings
TENB
$3.98B
$1.31M ﹤0.01%
44,071
+16,232
+58% +$441K
FWRD icon
2640
Forward Air
FWRD
$563M
$1.31M ﹤0.01%
26,246
-436
-2% -$21.4K
CHA
2641
DELISTED
China Telecom Corporation, LTD
CHA
$1.31M ﹤0.01%
46,504
-46,414
-50% -$1.47M
AGEN
2642
Agenus
AGEN
$312M
$1.3M ﹤0.01%
16,917
+11,782
+229% +$706K
CUE icon
2643
Cue Biopharma
CUE
$113M
$1.3M ﹤0.01%
+1,775
New +$1.29M
WLK icon
2644
Westlake Corp
WLK
$9.93B
$1.3M ﹤0.01%
24,323
-42,494
-64% -$1.96M
PGTI
2645
DELISTED
PGT, Inc.
PGTI
$1.3M ﹤0.01%
83,106
+19,599
+31% +$236K
MGY icon
2646
Magnolia Oil & Gas
MGY
$5.86B
$1.3M ﹤0.01%
214,554
+19,129
+10% +$104K
FSM icon
2647
Fortuna Silver Mines
FSM
$2.9B
$1.3M ﹤0.01%
254,680
+111,089
+77% +$402K
PRK icon
2648
Park National Corp
PRK
$3.71B
$1.29M ﹤0.01%
18,390
+6,327
+52% +$463K
STBA icon
2649
S&T Bancorp
STBA
$1.82B
$1.29M ﹤0.01%
55,095
+5,825
+12% +$141K
KN icon
2650
Knowles
KN
$3.36B
$1.29M ﹤0.01%
84,607
+3,489
+4% +$52K

Similar funds

Credit Suisse's Q2 2020 Portfolio in Review

As of Q2 2020, Credit Suisse held 4,310 positions worth $140B, up 21% from $116B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Credit Suisse's Q2 2020 filing shows 356 new, 1,988 increased, 1,282 reduced and 383 closed positions. Its largest new stake was Otis Worldwide: 10,131,011 shares worth $576M. The largest sale was Allergan plc, an estimated $1.9B.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Credit Suisse's largest Q2 2020 buy was Otis Worldwide: 10,131,011 shares worth $576M.
  • Credit Suisse added most to Microsoft in Q2 2020, an estimated $1.02B increase.
  • Credit Suisse's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $942M.
  • Credit Suisse fully exited Allergan plc in Q2 2020, selling an estimated $1.9B.
  • Credit Suisse's ten largest holdings make up 17% of its $140B portfolio in Q2 2020.
  • Credit Suisse opened 356 new positions and closed 383 in Q2 2020.
  • Credit Suisse's portfolio value rose 21% quarter-over-quarter to $140B.

Based on Credit Suisse's 13F filing for Q2 2020, filed 12 Aug 2020.